TRPV1 and Alzheimer disease: As genetic upregulation of TRPV1 is difficult to be used in the clinical treatment, we next wanted to determine whether pharmacological activation of TRPV1 by its agonist capsaicin (CAP, 1 mg/kg, i.p.)is able to ameliorate the spatial learning and memory deficits in AD model mice.